Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Preferred Shares Issued (2021)

Historic Preferred Shares Issued for Guided Therapeutics (GTHP) over the last 2 years, with Q2 2021 value amounting to -$382000.0.

  • Guided Therapeutics' Preferred Shares Issued changed N/A to -$382000.0 in Q2 2021 from the same period last year, while for Mar 2022 it was -$382000.0, marking a year-over-year decrease of 12101.21%. This contributed to the annual value of $1.4 million for FY2021, which is N/A changed from last year.
  • As of Q2 2021, Guided Therapeutics' Preferred Shares Issued stood at -$382000.0.
  • In the past 5 years, Guided Therapeutics' Preferred Shares Issued registered a high of $1.8 million during Q1 2021, and its lowest value of -$382000.0 during Q2 2021.